Ferroptosis in tumor immunity and therapy-Reference-Cited by-同舟云学术

Ferroptosis in tumor immunity and therapy

Published:2022-11 Issue:22 Volume:26 Page:5565-5579
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Gong Chuandong¹²³^ORCID,Ji Qiankun¹²³,Wu Miaojing¹²³,Tu Zewei¹²³,Lei Kunjian¹²³,Luo Min¹²³,Liu Junzhe¹²³,Lin Li¹²³,Li Kuangxun⁴,Li Jingying⁵,Huang Kai¹²³,Zhu Xingen¹²³

Affiliation:

1. Department of Neurosurgery The Second Affiliated Hospital of Nanchang University Nanchang China

2. Institute of Neuroscience, Nanchang University Nanchang China

3. Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases Nanchang China

4. College of Queen Mary Nanchang University Nanchang China

5. Department of Comprehensive Intensive Care Unit Second Affiliated Hospital of Nanchang University Nanchang China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17529

Reference158 articles.

1. Ferroptosis: process and function

2. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

3. Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

4. The release and activity of HMGB1 in ferroptosis

5. The molecular machinery of regulated cell death

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of tumor microenvironmental nutrients and metabolic molecules in ferroptosis: Mechanisms and clinical implications;Biomedicine & Pharmacotherapy;2024-10

2. ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis;BMC Cancer;2024-08-31

3. Ferroptosis: a potential target for acute lung injury;Inflammation Research;2024-08-17

4. Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death;Journal of Medicinal Chemistry;2024-08-15

5. Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan;Cancer Urology;2024-08-15